Ceapro Inc. Logo

Ceapro Inc.

CRPOF

(2.0)
Stock Price

0,17 USD

-21.14% ROA

-21.67% ROE

-2.92x PER

Market Cap.

18.178.851,13 USD

8.28% DER

0% Yield

-69.73% NPM

Ceapro Inc. Stock Analysis

Ceapro Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Ceapro Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.66x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a minimal amount of debt (8%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 ROE

ROE in an average range (1.11%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 ROA

The stock's ROA (0.97%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

6 Buffet Intrinsic Value

The company's stock seems undervalued (4) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

7 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

9 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

10 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

11 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

Ceapro Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Ceapro Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Ceapro Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Ceapro Inc. Revenue
Year Revenue Growth
1996 600.000
1997 2.300.000 73.91%
1998 400.000 -475%
1999 300.000 -33.33%
2000 808.854 62.91%
2001 1.149.443 29.63%
2002 1.511.512 23.95%
2003 2.218.262 31.86%
2004 1.956.961 -13.35%
2005 2.683.433 27.07%
2006 3.310.323 18.94%
2007 3.447.694 3.98%
2008 4.228.073 18.46%
2009 4.370.070 3.25%
2010 5.576.636 21.64%
2011 5.786.174 3.62%
2012 5.165.276 -12.02%
2013 6.524.062 20.83%
2014 8.890.256 26.62%
2015 10.667.442 16.66%
2016 13.673.962 21.99%
2017 12.925.825 -5.79%
2018 11.592.666 -11.5%
2019 12.880.006 9.99%
2020 15.121.282 14.82%
2021 17.195.329 12.06%
2022 18.839.607 8.73%
2023 10.475.892 -79.84%
2023 9.633.400 -8.75%
2024 11.095.152 13.17%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Ceapro Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1996 100.000
1997 2.300.000 95.65%
1998 800.000 -187.5%
1999 400.000 -100%
2000 293.428 -36.32%
2001 396.998 26.09%
2002 259.061 -53.24%
2003 353.744 26.77%
2004 302.487 -16.95%
2005 162.833 -85.77%
2006 365.424 55.44%
2007 695.661 47.47%
2008 0 0%
2009 0 0%
2010 774.059 100%
2011 996.719 22.34%
2012 856.191 -16.41%
2013 731.174 -17.1%
2014 578.361 -26.42%
2015 625.214 7.49%
2016 919.121 31.98%
2017 1.606.332 42.78%
2018 2.665.838 39.74%
2019 2.393.607 -11.37%
2020 1.881.883 -27.19%
2021 3.779.102 50.2%
2022 1.788.666 -111.28%
2023 2.338.660 23.52%
2023 2.751.473 15%
2024 5.502.620 50%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Ceapro Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1996 0
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 1.688.978 100%
2009 1.675.007 -0.83%
2010 1.297.225 -29.12%
2011 1.374.030 5.59%
2012 1.795.476 23.47%
2013 1.709.053 -5.06%
2014 1.984.025 13.86%
2015 2.519.119 21.24%
2016 2.187.181 -15.18%
2017 2.840.605 23%
2018 3.000.005 5.31%
2019 2.952.488 -1.61%
2020 3.282.754 10.06%
2021 3.239.672 -1.33%
2022 3.700.498 12.45%
2023 7.891.536 53.11%
2023 7.419.593 -6.36%
2024 8.918.112 16.8%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Ceapro Inc. EBITDA
Year EBITDA Growth
1996 -1.800.000
1997 -5.600.000 67.86%
1998 -1.600.000 -250%
1999 -1.100.000 -45.45%
2000 -780.050 -41.02%
2001 -667.883 -16.79%
2002 -315.783 -111.5%
2003 -330.371 4.42%
2004 -332.281 0.57%
2005 158.334 309.86%
2006 -148.935 206.31%
2007 -393.566 62.16%
2008 -889.101 55.73%
2009 571.462 255.58%
2010 1.406.620 59.37%
2011 1.063.001 -32.33%
2012 -109.121 1074.15%
2013 866.326 112.6%
2014 2.359.607 63.29%
2015 4.075.149 42.1%
2016 6.396.367 36.29%
2017 110.923 -5666.49%
2018 371.476 70.14%
2019 1.097.450 66.15%
2020 4.038.924 72.83%
2021 4.722.272 14.47%
2022 7.536.718 37.34%
2023 -3.559.348 311.74%
2023 -4.308.580 17.39%
2024 -7.856.600 45.16%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Ceapro Inc. Gross Profit
Year Gross Profit Growth
1996 100.000
1997 400.000 75%
1998 300.000 -33.33%
1999 100.000 -200%
2000 291.171 65.66%
2001 421.032 30.84%
2002 757.383 44.41%
2003 1.290.147 41.29%
2004 934.130 -38.11%
2005 1.559.827 40.11%
2006 1.578.992 1.21%
2007 1.653.697 4.52%
2008 1.586.885 -4.21%
2009 2.118.046 25.08%
2010 2.535.167 16.45%
2011 3.247.827 21.94%
2012 2.448.671 -32.64%
2013 3.098.814 20.98%
2014 4.763.772 34.95%
2015 7.028.597 32.22%
2016 9.352.822 24.85%
2017 7.272.118 -28.61%
2018 6.138.198 -18.47%
2019 5.445.352 -12.72%
2020 7.622.286 28.56%
2021 9.689.293 21.33%
2022 11.017.699 12.06%
2023 4.320.092 -155.03%
2023 3.563.513 -21.23%
2024 4.244.660 16.05%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Ceapro Inc. Net Profit
Year Net Profit Growth
1996 -3.700.000
1997 -19.800.000 81.31%
1998 -14.300.000 -38.46%
1999 -900.000 -1488.89%
2000 -915.895 1.74%
2001 -346.103 -164.63%
2002 115.774 398.95%
2003 442.038 73.81%
2004 -397.737 211.14%
2005 -57.007 -597.7%
2006 -272.357 79.07%
2007 -1.389.334 80.4%
2008 -3.599.469 61.4%
2009 -69.349 -5090.37%
2010 463.722 114.95%
2011 577.573 19.71%
2012 -538.353 207.29%
2013 175.808 406.22%
2014 1.593.795 88.97%
2015 4.922.151 67.62%
2016 3.619.895 -35.97%
2017 -958.275 477.75%
2018 -315.537 -203.7%
2019 -1.132.628 72.14%
2020 1.856.100 161.02%
2021 3.365.455 44.85%
2022 4.398.098 23.48%
2023 -4.161.828 205.68%
2023 -4.709.893 11.64%
2024 -7.560.752 37.71%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Ceapro Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1996 0
1997 -1 100%
1998 -1 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Ceapro Inc. Free Cashflow
Year Free Cashflow Growth
1996 -2.100.000
1997 -22.000.000 90.45%
1998 -2.700.000 -714.81%
1999 -400.000 -575%
2000 -792.516 49.53%
2001 -739.664 -7.15%
2002 -299.060 -147.33%
2003 -63.066 -374.2%
2004 -569.379 88.92%
2005 -549.481 -3.62%
2006 86.087 738.29%
2007 -2.688.715 103.2%
2008 -1.412.649 -90.33%
2009 -1.021.154 -38.34%
2010 269.819 478.46%
2011 667.351 59.57%
2012 -316.703 310.72%
2013 -172.621 -83.47%
2014 -2.176.494 92.07%
2015 -223.424 -874.15%
2016 -96.020 -132.68%
2017 -2.317.329 95.86%
2018 -3.377.225 31.38%
2019 731.713 561.55%
2020 3.833.975 80.92%
2021 2.801.577 -36.85%
2022 6.295.582 55.5%
2023 -4.603.696 236.75%
2023 56.373 8266.49%
2024 -3.999.658 101.41%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Ceapro Inc. Operating Cashflow
Year Operating Cashflow Growth
1996 -1.900.000
1997 -4.500.000 57.78%
1998 -2.500.000 -80%
1999 -300.000 -733.33%
2000 -759.412 60.5%
2001 -728.253 -4.28%
2002 -102.719 -608.98%
2003 70.571 245.55%
2004 -92.149 176.58%
2005 -428.375 78.49%
2006 163.872 361.41%
2007 -1.086.310 115.09%
2008 -1.106.758 1.85%
2009 -969.058 -14.21%
2010 360.911 368.5%
2011 808.240 55.35%
2012 -117.214 789.54%
2013 490.018 123.92%
2014 2.443.372 79.95%
2015 3.982.395 38.65%
2016 4.747.960 16.12%
2017 1.573.006 -201.84%
2018 -2.122.130 174.12%
2019 882.116 340.57%
2020 4.453.019 80.19%
2021 3.510.480 -26.85%
2022 6.636.649 47.1%
2023 -3.622.963 283.18%
2023 195.560 1952.61%
2024 -3.238.349 106.04%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Ceapro Inc. Capital Expenditure
Year Capital Expenditure Growth
1996 200.000
1997 17.500.000 98.86%
1998 200.000 -8650%
1999 100.000 -100%
2000 33.104 -202.08%
2001 11.411 -190.11%
2002 196.341 94.19%
2003 133.637 -46.92%
2004 477.230 72%
2005 121.106 -294.06%
2006 77.785 -55.69%
2007 1.602.405 95.15%
2008 305.891 -423.85%
2009 52.096 -487.17%
2010 91.092 42.81%
2011 140.889 35.34%
2012 199.489 29.38%
2013 662.639 69.89%
2014 4.619.866 85.66%
2015 4.205.819 -9.84%
2016 4.843.980 13.17%
2017 3.890.335 -24.51%
2018 1.255.095 -209.96%
2019 150.403 -734.49%
2020 619.044 75.7%
2021 708.903 12.68%
2022 341.067 -107.85%
2023 980.733 65.22%
2023 139.187 -604.62%
2024 761.309 81.72%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Ceapro Inc. Equity
Year Equity Growth
1996 8.000.000
1997 9.400.000 14.89%
1998 -1.100.000 954.55%
1999 -1.900.000 42.11%
2000 -2.390.977 20.53%
2001 -1.137.304 -110.23%
2002 -652.969 -74.17%
2003 382.230 270.83%
2004 114.066 -235.1%
2005 461.337 75.27%
2006 303.799 -51.86%
2007 1.553.652 80.45%
2008 -1.931.128 180.45%
2009 -1.372.743 -40.68%
2010 -551.766 -148.79%
2011 517.756 206.57%
2012 13.564 -3717.13%
2013 244.493 94.45%
2014 2.092.033 88.31%
2015 7.876.534 73.44%
2016 22.400.708 64.84%
2017 22.543.949 0.64%
2018 23.215.001 2.89%
2019 22.312.174 -4.05%
2020 24.309.967 8.22%
2021 27.197.075 10.62%
2022 32.289.089 15.77%
2023 27.855.101 -15.92%
2023 29.963.370 7.04%
2024 25.984.312 -15.31%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Ceapro Inc. Assets
Year Assets Growth
1996 18.600.000
1997 13.100.000 -41.98%
1998 500.000 -2520%
1999 300.000 -66.67%
2000 294.148 -1.99%
2001 373.326 21.21%
2002 645.347 42.15%
2003 1.255.312 48.59%
2004 1.717.820 26.92%
2005 2.418.934 28.98%
2006 2.062.846 -17.26%
2007 4.587.593 55.03%
2008 3.287.394 -39.55%
2009 2.770.654 -18.65%
2010 2.819.759 1.74%
2011 4.170.790 32.39%
2012 3.885.968 -7.33%
2013 5.097.002 23.76%
2014 7.683.229 33.66%
2015 15.703.474 51.07%
2016 26.391.634 40.5%
2017 27.807.905 5.09%
2018 25.324.623 -9.81%
2019 27.269.158 7.13%
2020 29.223.731 6.69%
2021 30.528.049 4.27%
2022 37.734.471 19.1%
2023 31.445.834 -20%
2023 33.944.212 7.36%
2024 29.409.669 -15.42%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Ceapro Inc. Liabilities
Year Liabilities Growth
1996 10.600.000
1997 3.700.000 -186.49%
1998 1.600.000 -131.25%
1999 2.200.000 27.27%
2000 2.685.125 18.07%
2001 1.510.630 -77.75%
2002 1.298.316 -16.35%
2003 873.082 -48.7%
2004 1.603.754 45.56%
2005 1.957.597 18.08%
2006 1.759.047 -11.29%
2007 3.033.941 42.02%
2008 5.218.522 41.86%
2009 4.143.397 -25.95%
2010 3.371.525 -22.89%
2011 3.653.034 7.71%
2012 3.872.404 5.66%
2013 4.852.509 20.2%
2014 5.591.196 13.21%
2015 7.826.940 28.56%
2016 3.990.926 -96.12%
2017 5.263.956 24.18%
2018 2.109.622 -149.52%
2019 4.956.984 57.44%
2020 4.913.764 -0.88%
2021 3.330.974 -47.52%
2022 5.445.382 38.83%
2023 3.590.733 -51.65%
2023 3.980.842 9.8%
2024 3.425.357 -16.22%

Ceapro Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.11
Net Income per Share
-0.08
Price to Earning Ratio
-2.92x
Price To Sales Ratio
2.04x
POCF Ratio
-3.17
PFCF Ratio
-2.44
Price to Book Ratio
0.7
EV to Sales
1.75
EV Over EBITDA
-2.58
EV to Operating CashFlow
-2.71
EV to FreeCashFlow
-2.09
Earnings Yield
-0.34
FreeCashFlow Yield
-0.41
Market Cap
0,02 Bil.
Enterprise Value
0,02 Bil.
Graham Number
0.77
Graham NetNet
0.07

Income Statement Metrics

Net Income per Share
-0.08
Income Quality
0.92
ROE
-0.22
Return On Assets
-0.21
Return On Capital Employed
-0.3
Net Income per EBT
0.79
EBT Per Ebit
0.95
Ebit per Revenue
-0.93
Effective Tax Rate
0.21

Margins

Sales, General, & Administrative to Revenue
0.91
Research & Developement to Revenue
0.4
Stock Based Compensation to Revenue
0.02
Gross Profit Margin
0.37
Operating Profit Margin
-0.93
Pretax Profit Margin
-0.88
Net Profit Margin
-0.7

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.07
Free CashFlow per Share
-0.1
Capex to Operating CashFlow
0.3
Capex to Revenue
-0.19
Capex to Depreciation
-0.87
Return on Invested Capital
-0.23
Return on Tangible Assets
-0.21
Days Sales Outstanding
77.11
Days Payables Outstanding
82.99
Days of Inventory on Hand
311.3
Receivables Turnover
4.73
Payables Turnover
4.4
Inventory Turnover
1.17
Capex per Share
-0.02

Balance Sheet

Cash per Share
0,06
Book Value per Share
0,33
Tangible Book Value per Share
0.33
Shareholders Equity per Share
0.33
Interest Debt per Share
0.03
Debt to Equity
0.08
Debt to Assets
0.07
Net Debt to EBITDA
0.43
Current Ratio
7.1
Tangible Asset Value
0,03 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
0.08
Working Capital
0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
5043844
Debt to Market Cap
0.12

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Ceapro Inc. Dividends
Year Dividends Growth

Ceapro Inc. Profile

About Ceapro Inc.

Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. It operates in two segments, Active Ingredient Product Technology Industry and Cosmeceutical Industry. The Active Ingredient Product Technology Industry segment develops proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. The Cosmeceutical Industry segment is involved in the development and commercialization of anti-aging products derived from natural active ingredients sold directly to the end-user primarily through online website sales and through select natural products stores. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.

CEO
Mr. Gilles R. Gagnon ICD.D, M.
Employee
0
Address
7824 – 51 Avenue NW
Edmonton, T6E 6W2

Ceapro Inc. Executives & BODs

Ceapro Inc. Executives & BODs
# Name Age
1 Dr. Bernhard Seifried
Senior Director of Research & Technology
70
2 Ms. Stacy Prefontaine C.A., CPA, CA, CPA
Chief Financial Officer & Corporate Secretary
70
3 Mr. Michel Regnier P. Eng.
Senior Vice President of Technical Operations
70
4 Mr. Gilles R. Gagnon ICD.D, M.B.A., M.Sc.
Chief Executive Officer, President & Director
70

Ceapro Inc. Competitors